Showing results (2561-2570 of 3,349) with videos related to

Sort By:
Pageof 335
Malaria Journal|March 18, 2025
Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infectionAndrea A Berry, Thomas L Richie, L W Preston Church, et al.
Blood|December 25, 2013
Washing older blood units before transfusion reduces plasma iron and improves outcomes in experimental canine pneumoniaIrene Cortés-Puch, Dong Wang, Junfeng Sun, et al.
The Journal of Infectious Diseases|November 4, 2005
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group StudyDavid W Haas, Laura M Smeaton, Robert W Shafer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2015
Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with MelanomaDavid S Hong, Razelle Kurzrock, Jennifer J Wheler, et al.
Cell Death and Differentiation|January 17, 2015
LAMC2 enhances the metastatic potential of lung adenocarcinomaY W Moon, G Rao, J J Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant MelanomaMartin Schuler, Lisa Zimmer, Kevin B Kim, et al.
Scientific Reports|July 27, 2024
X-ray diffraction of metastable structures from supercooled liquid hydrogenLuke B Fletcher, Abraham L Levitan, Emma E McBride, et al.
Genomics Data|June 20, 2015
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous CapS T Nurnberg, K Cheng, A Raiesdana, et al.
The New England Journal of Medicine|February 7, 2019
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent PorphyriaEliane Sardh, Pauline Harper, Manisha Balwani, et al.
Oncogene|February 9, 2016
Novel strategy for a bispecific antibody: induction of dual target internalization and degradationJ M Lee, S H Lee, J-W Hwang, et al.
Pageof 335